SRTA Q3 2024 Earnings — Strata Critical Medical, Inc. Revenue & Financial Results | Market Cap Arena

SRTAStrata Critical Medical, Inc.

$410M

Q3 2024 Earnings

Industrials Airlines, Airports & Air Services

Income Statement

Revenue

$75M+4.8% YoY

Gross Profit

$20M26.5% margin

Operating Income

-$4M-4.7% margin

Net Income

-$2M-2.6% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

+10.2%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

-$4M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$283M

Total Liabilities

$49M

Stockholders' Equity

$233M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$75M	$71M	+4.8%
Gross Profit	$20M	$16M	+27.3%
Operating Income	-$4M	-$7M	+52.5%
Net Income	-$2M	$289,000	-776.1%

Revenue Segments

Passenger Segment

$39M52%

Medical Segment

$36M48%

Geographic Segments

UNITED STATES

$63M85%

Non-US

$12M15%